glp-1 obesity drug news today sep 30 2025 Chart: 1 in 8 Americans Now Use Drugs for Weight Loss This new Medicare program offers

Important conclusions drawn from recent meta-analyses involving over 300,000 patients report that while the retained gastric contents are significantly increased (fivefold to tenfold increase

Data are presented as medians (interquartile ranges) or frequencies (%), and Wilcoxon signed-rank tests and Mann-Whitney U tests were used for paired and nonpaired group comparisons, respectively

Constipation is a common but often overlooked side effect in people taking GLP-1 receptor agonists, a class of medications widely used to treat obesity and type 2 diabetes

Discover the transformative impact of GLP-1 agonists, originally a diabetes treatment, on thousands of peoples weight-loss journey.

Thats why theres a lot of excitement around a new pill form of the drug

However, renal effects of GLP-1 in heart failure (HF) has not been elucidated